logo-loader

Full interview: BioCorRx presents new preclinical data showing VDM-001 blocks fentanyl

Published: 08:34 04 Dec 2019 EST

BioCorRx Inc (OTCMKTS:BICX) CEO Brady Granier tells Proactive early data suggests its drug therapy may prevent overdoses from fentanyl.

Granier says while VDM-001 is still in its early days, with more validation studies to come, the drug candidate could represent an alternative to naloxone in the overdose-reversal market.

Full interview: BioCorRx offers medical professionals free use of its...

BioCorRx Inc (OTCQB:BICX) CEO Brady Granier tells Proactive the California-based company will help support vulnerable patients recover from alcohol or drug dependencies through the coronavirus pandemic. Granier says the addiction treatment solutions company is offering free access to its...

on 04/07/2020